Lexaria Bioscience Corp (LEXX)

[Shawking]

Lexaria does not say why trading is up



2017-12-08 13:11 ET - News Release


An anonymous director reports

LEXARIA ANNOUNCES NO MATERIAL DEVELOPMENTS

At the request of the Investment Industry Regulatory Organization of Canada, Lexaria Bioscience Corp. is not aware of any undisclosed material change to the corporation's business or operations and it has no material change to report at this time. Lexaria conducts technology licence sales activities as part of its everyday business activities and will disclose all material sales and licensing agreements if and as they occur.

About Lexaria Bioscience Corp.

Lexaria Bioscience has developed and outlicenses its disruptive patented technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the United States and in Australia related to edible forms of cannabinoids. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.

We seek Safe Harbor.